Novo Nordisk A/S 2017 AR2
The report highlights Novo Nordisk's performance in 2017, during which the company achieved a 2% sales growth and 5% operating profit growth in local currencies. Key milestones included the FDA approval of Ozempic® (semaglutide) and Fiasp®, as well as label updates for Victoza® and Tresiba® demonstrating cardiovascular and hypoglycaemia benefits. In addition, the company advanced its R&D strategy to expand into other serious chronic diseases like NASH and cardiovascular disease. On the sustainability front, Novo Nordisk increased its share of renewable power to 79% and continued its commitment to providing low-priced insulin in least developed countries.
Company: Novo Nordisk A/S
Sector: Manufacturing
Country: Denmark
Year: 2017
Type: AR2
Pages: 121
Back to company
Novo Nordisk A/S
Annual Report
The report highlights Novo Nordisk's performance in 2017, during which the company achieved a 2% sales growth and 5% operating profit growth in local currencies. Key milestones included the FDA approval of Ozempic® (semaglutide) and Fiasp®, as well as label updates for Victoza® and Tresiba® demonstrating cardiovascular and hypoglycaemia benefits. In addition, the company advanced its R&D strategy to expand into other serious chronic diseases like NASH and cardiovascular disease. On the sustainability front, Novo Nordisk increased its share of renewable power to 79% and continued its commitment to providing low-priced insulin in least developed countries.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2017
Reporting Period
Jan 1, 2017 - Dec 31, 2017
Fiscal Year
2017
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women in Management
Workplace Fatalities
Employees